Targeted therapy in Multiple Myeloma: Results of first phase I study with everolimus (RAD001)

被引：0
|
作者：
Guenther, A. [1 ]
Baumann, P. [2 ]
Burger, R. [1 ]
Klapper, W. [3 ]
Schmidmaier, R. [2 ]
Gramatzki, M. [1 ]
机构：
[1] UKSH Campus Kiel, Med Klin 2, Sekt Stammzell & Immuntherapie, Kiel, Germany
[2] Klinikum Univ Munchen, Med Klin Innenstadt, Munich, Germany
[3] UKSH Campus Kiel, Inst Pathol, Sekt Hamatopathol, Kiel, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [31] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, A. P.
    Tarhini, A.
    Petro, D.
    Flaugh, R.
    Vallabhaneni, G.
    Belani, C. P.
    Friedland, D.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Phase I Study of Pasireotide (SOM230) in Combination With Everolimus (RAD001) in Patients With Advanced Neuroendocrine Tumors (NET)
    Chan, Jennifer A.
    Ryan, David P.
    Fuchs, Charles S.
    Zhu, Andrew X.
    Abrams, Thomas A.
    Wolpin, Brian M.
    Casey, Carolyn
    Regan, Eileen
    Cavanaugh, Kristen
    Kulke, Matthew H.
    PANCREAS, 2011, 40 (02) : 325 - 325
  • [33] Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Stoller, R. G.
    Petro, D.
    Flaugh, R.
    Hershberger, P. A.
    Belani, C. P.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM)
    Dronca, R. S.
    Perez, D. G.
    Allred, J.
    Maples, W. J.
    Creagan, E. T.
    Pockaj, B. A.
    Kaur, J. S.
    Moore, T. D.
    Marchello, B. T.
    Markovic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
    Moulder, Stacy
    Gladish, Gregory
    Ensor, Joe
    Gonzalez-Angulo, Ana Maria
    Cristofanilli, Massimo
    Murray, James L.
    Booser, Daniel
    Giordano, Sharon H.
    Brewster, Abeena
    Moore, Julia
    Rivera, Edgardo
    Hortobagyi, Gabriel N.
    Tran, Hai T.
    CANCER, 2012, 118 (09) : 2378 - 2384
  • [36] Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)
    Whorf, R. C.
    Hainsworth, J. D.
    Spigel, D. R.
    Yardley, D. A.
    Burris, H. A., III
    Waterhouse, D. M.
    Vazquez, E. R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, Athanasios
    Tarhini, Ahmad
    Petro, Daniel
    Flaugh, Rick
    Vallabhaneni, Geetha
    Belani, Chandra
    Friedland, David
    Argiris, Athanassios
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S464 - S464
  • [38] PHASE I TRIAL OF RAD001 (EVEROLIMUS) IN COMBINATION WITH RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Deutsch, E.
    Lepechoux, C.
    Pignon, J. P.
    Tao, Y. T.
    Rivera, S.
    Bourgier, B. C.
    Angokai, M.
    Bahleda, R.
    Slimane, K.
    Angevin, E.
    Besse, B. B.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2013, 24 : 9 - 9
  • [39] Prospective, Multicenter Study of the MTOR Inhibitor Everolimus (RAD001) As Primary Therapy in Waldenstrom's Macroglobulinemia
    Treon, Steven P.
    Tripsas, Christina K.
    Ioakimidis, Leukothea
    Warren, Diane
    Patterson, Christopher
    Heffner, Leonard
    Eradat, Herbert
    Gregory, Stephanie A.
    Thomas, Sheeba
    Advani, Ranjana
    Baz, Rachid
    Badros, Ashraf Z.
    Matous, Jeffrey
    Anderson, Kenneth C.
    Ghobrial, Irene M.
    BLOOD, 2011, 118 (21) : 1273 - 1274
  • [40] Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia
    Crazzolara, Roman
    Cisterne, Adam
    Thien, Marilyn
    Hewson, John
    Baraz, Rana
    Bradstock, Kenneth F.
    Bendall, Linda J.
    BLOOD, 2009, 113 (14) : 3297 - 3306
12345